CIK 0001034842 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 294.3 M | 120.2 M |
| Net income (USD) | 367.0 M | -58.6 M |
| Diluted EPS (USD/shares) | 19.48 | -3.44 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-03 | 4 | FORM 4 | 2026-09-01 |
| 2026-09-03 | 4 | FORM 4 | 2026-09-01 |
| 2026-09-03 | 4 | FORM 4 | 2026-09-01 |
| 2026-09-03 | 4 | FORM 4 | 2026-09-01 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | S-8 | S-8 | |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-01 | 8-K | 8-K items 5.02 | 2026-06-25 |
| 2026-06-24 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-22 | 144 | 144 | |
| 2026-06-17 | 8-K | 8-K items 2.01 | 2026-06-11 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-06-03 | 4 | FORM 4 | 2026-06-01 |
| 2026-05-28 | 4 | FORM 4 | 2026-05-26 |
Forms on file (last 1,000): 4 381, 8-K 202, SC 13G/A 109, 10-Q 57, S-8 23, 3 21, SC 13G 20, CT ORDER 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RIGL (0.002 USD), /gw/filings/filings?ticker=RIGL&form=8-K, /gw/filings/facts?ticker=RIGL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange